[8-K] Cyclacel Pharmaceuticals, Inc. 6% Cnvrtbl. Prfrd. Stock Reports Material Event
Campbell Soup Company (CPB) Form 4 filing 鈥� insider activity. On 26 June 2025, Director Sarah Hofstetter acquired 1,348.51 units of phantom stock, an award whose value mirrors one share of common stock. The units were granted at a stated price of $0 under the company鈥檚 Supplemental Retirement Plan and are fully vested. After the transaction, Hofstetter鈥檚 total phantom-stock holdings rose to 25,710.86 units, which now include 262.25 units accumulated through dividend reinvestment since her last report. Phantom stock will be settled in cash upon the director鈥檚 retirement, resignation, or termination. No sales or disposals were reported, and there were no changes in non-derivative common-stock ownership.
Because the award represents routine director compensation and has an estimated market value far below materiality thresholds relative to Campbell鈥檚 market capitalisation, the filing is considered informational rather than market-moving. Nevertheless, the absence of sales and the continuing accumulation of stock-equivalent units signal ongoing alignment of director interests with shareholder value.
Campbell Soup Company (CPB) Modulo 4 鈥� attivit脿 degli insider. Il 26 giugno 2025, la Direttrice Sarah Hofstetter ha acquisito 1.348,51 unit脿 di phantom stock, un premio il cui valore corrisponde a una azione ordinaria. Le unit脿 sono state assegnate a un prezzo nominale di 0$ nell'ambito del Piano Pensionistico Supplementare della societ脿 e sono completamente maturate. Dopo la transazione, il totale delle unit脿 di phantom stock detenute da Hofstetter 猫 salito a 25.710,86 unit脿, comprensive di 262,25 unit脿 accumulate tramite il reinvestimento dei dividendi dalla sua ultima segnalazione. Il phantom stock verr脿 liquidato in contanti al momento del pensionamento, dimissioni o licenziamento della direttrice. Non sono state segnalate vendite o cessioni, n茅 variazioni nella propriet脿 di azioni ordinarie non derivate.
Poich茅 il premio rappresenta una normale remunerazione per i direttori e il suo valore di mercato stimato 猫 ben al di sotto delle soglie di rilevanza rispetto alla capitalizzazione di mercato di Campbell, la segnalazione 猫 considerata informativa e non influente sul mercato. Tuttavia, l'assenza di vendite e la continua accumulazione di unit脿 equivalenti a azioni indicano un allineamento costante degli interessi della direttrice con il valore per gli azionisti.
Campbell Soup Company (CPB) presentaci贸n Formulario 4 鈥� actividad de insiders. El 26 de junio de 2025, la Directora Sarah Hofstetter 补诲辩耻颈谤颈贸 1,348.51 unidades de phantom stock, un premio cuyo valor refleja una acci贸n com煤n. Las unidades fueron otorgadas a un precio declarado de $0 bajo el Plan Suplementario de Jubilaci贸n de la empresa y est谩n totalmente consolidadas. Tras la transacci贸n, la tenencia total de phantom stock de Hofstetter aument贸 a 25,710.86 unidades, que ahora incluyen 262.25 unidades acumuladas mediante reinversi贸n de dividendos desde su 煤ltimo reporte. El phantom stock se liquidar谩 en efectivo al momento de la jubilaci贸n, renuncia o despido de la directora. No se reportaron ventas ni disposiciones, y no hubo cambios en la propiedad de acciones comunes no derivadas.
Dado que el premio representa una compensaci贸n rutinaria para directores y su valor de mercado estimado est谩 muy por debajo de los umbrales de materialidad en relaci贸n con la capitalizaci贸n de mercado de Campbell, la presentaci贸n se considera informativa y no que mueva el mercado. Sin embargo, la ausencia de ventas y la continua acumulaci贸n de unidades equivalentes a acciones indican una alineaci贸n constante de los intereses de la directora con el valor para los accionistas.
旌犽波 靾橅攧 旎错嵓雼�(CPB) Form 4 鞝滌稖 鈥� 雮措秬鞛� 頇滊彊. 2025雲� 6鞗� 26鞚�, 鞚挫偓 Sarah Hofstetter臧赌 韺厐 鞀ろ啞 1,348.51 雼渼毳� 旆摑頄堨姷雼堧嫟. 韺厐 鞀ろ啞鞚� 氤错喌欤� 頃� 欤检潣 臧赌旃橂ゼ 氚橃榿頃橂姅 氤挫儊鞛呺媹雼�. 頃措嫻 雼渼霌れ潃 須岇偓鞚� 於旉岸� 韲挫鞐瓣笀 瓿勴殟 頃橃棎 氇呾嫓霅� 臧赌瓴� $0搿� 攵�鞐悩鞐堨溂氅�, 鞕勳爠頌� 氩犾姢韺�(甓岆Μ 頇曥爼)霅� 靸來儨鞛呺媹雼�. 鞚措矆 瓯半灅 頉� Hofstetter 鞚挫偓鞚� 韺厐 鞀ろ啞 齑� 氤挫湢霟夓潃 25,710.86 雼渼搿� 歃濌岸捻枅鞙茧┌, 鞚� 欷� 262.25 雼渼電� 歆�雮� 氤搓碃 鞚错泟 氚半嫻旮� 鞛埇鞛愲ゼ 韱淀暣 雸勳爜霅� 瓴冹瀰雼堧嫟. 韺厐 鞀ろ啞鞚� 鞚挫偓鞚� 鞚�韲�, 靷瀯 霕愲姅 頃搓碃 鞁� 順勱笀鞙茧 鞝曥偘霅╇媹雼�. 韺愲Г雮� 觳橂秳鞚� 氤搓碃霅橃 鞎婌晿鞙茧┌, 牍勴寣靸� 氤错喌欤� 靻岇湢甓� 氤�頇旊弰 鞐嗢棃鞀惦媹雼�.
鞚� 氤挫儊鞚� 鞚挫偓鞐� 雽�頃� 鞚检儊鞝侅澑 氤挫垬鞚措┌, 旌犽波鞚� 鞁滉岸撵礉鞎� 雽�牍� 欷戩殧靹� 旮办鞐� 頉敩 氇� 氙胳箻電� 於旍爼 鞁滌灔 臧赌旃橂ゼ 臧赌歆�瓿� 鞛堨柎, 鞝滌稖 雮挫毄鞚� 鞝曤炒 鞝滉车 氇╈爜鞚挫 鞁滌灔鞐� 鞓來枼鞚� 氙胳範 毵岉暅 靷晥鞙茧 臧勳＜霅橃 鞎婌姷雼堧嫟. 攴鸽熂鞐愲弰 攵堦惮頃橁碃 韺愲Г臧赌 鞐嗞碃 欤检嫕 霌标岸� 雼渼鞚� 歆�靻嶌爜 雸勳爜鞚� 鞚挫偓鞚� 鞚错暣甏�瓿勱岸� 欤检＜ 臧赌旃橃檧 瓿勳啀 鞚检箻頃橁碃 鞛堨潓鞚� 雮橅儉雰呺媹雼�.
Campbell Soup Company (CPB) d茅p么t du formulaire 4 鈥� activit茅 des initi茅s. Le 26 juin 2025, la directrice Sarah Hofstetter a acquis 1 348,51 unit茅s de phantom stock, une attribution dont la valeur refl猫te une action ordinaire. Les unit茅s ont 茅t茅 attribu茅es 脿 un prix d茅clar茅 de 0 $ dans le cadre du Plan de Retraite Suppl茅mentaire de la soci茅t茅 et sont enti猫rement acquises. Apr猫s la transaction, la d茅tention totale de phantom stock de Hofstetter est pass茅e 脿 25 710,86 unit茅s, incluant 262,25 unit茅s accumul茅es par r茅investissement des dividendes depuis son dernier rapport. Le phantom stock sera r茅gl茅 en esp猫ces lors de la retraite, de la d茅mission ou du licenciement de la directrice. Aucune vente ou cession n鈥檃 茅t茅 signal茅e, et il n鈥檡 a eu aucun changement dans la d茅tention d鈥檃ctions ordinaires non d茅riv茅es.
脡tant donn茅 que cette attribution repr茅sente une r茅mun茅ration habituelle des administrateurs et que sa valeur marchande estim茅e est bien en dessous des seuils de mat茅rialit茅 par rapport 脿 la capitalisation boursi猫re de Campbell, le d茅p么t est consid茅r茅 comme informatif et non susceptible d鈥檌nfluencer le march茅. N茅anmoins, l鈥檃bsence de ventes et l鈥檃ccumulation continue d鈥檜nit茅s 茅quivalentes 脿 des actions indiquent un alignement constant des int茅r锚ts de la directrice avec la valeur pour les actionnaires.
Campbell Soup Company (CPB) Form 4 Einreichung 鈥� Insider-Aktivit盲ten. Am 26. Juni 2025 erwarb die Direktorin Sarah Hofstetter 1.348,51 Einheiten von Phantomaktien, einer Zuwendung, deren Wert einer Stammaktie entspricht. Die Einheiten wurden zu einem festgelegten Preis von 0 $ im Rahmen des erg盲nzenden Altersvorsorgeplans des Unternehmens gew盲hrt und sind vollst盲ndig unverfallbar. Nach der Transaktion stieg Hofstetters Gesamtbestand an Phantomaktien auf 25.710,86 Einheiten, einschlie脽lich 262,25 Einheiten, die seit ihrem letzten Bericht durch Dividenden-Reinvestition angesammelt wurden. Phantomaktien werden bei Renteneintritt, R眉cktritt oder K眉ndigung der Direktorin in bar abgewickelt. Es wurden keine Verk盲ufe oder Ver盲u脽erungen gemeldet, und es gab keine 脛nderungen im Besitz von nicht-derivierten Stammaktien.
Da die Zuwendung eine routinem盲脽ige Direktorenverg眉tung darstellt und der gesch盲tzte Marktwert im Vergleich zur Marktkapitalisierung von Campbell weit unter den Wesentlichkeitsschwellen liegt, wird die Einreichung als informativ und nicht als marktbewegend eingestuft. Dennoch signalisieren das Ausbleiben von Verk盲ufen und die fortlaufende Ansammlung von aktien盲quivalenten Einheiten eine anhaltende 脺bereinstimmung der Interessen der Direktorin mit dem Wert f眉r die Aktion盲re.
- Director acquired additional phantom shares rather than selling, indicating continued alignment with shareholder interests.
- No dilution risk as phantom stock settles in cash under the Supplemental Retirement Plan.
- None.
Insights
TL;DR: Routine phantom-stock grant; mildly shareholder-friendly, financially immaterial.
The Form 4 shows Hofstetter receiving 1,348 phantom shares, lifting her stake to 25,711 units. With CPB trading near the mid-$40s, the grant is worth roughly $60k鈥攊mmaterial versus Campbell鈥檚 $14 bn market cap. No shares were sold, so signal remains neutral-to-slightly positive on governance grounds. Importantly, phantom stock settles in cash, so dilution is not a concern. Overall, I see no immediate valuation impact.
TL;DR: Standard director compensation, reflects alignment, not impactful.
Phantom-stock accruals are common for outside directors and foster long-term alignment without issuing new shares. The grant is fully vested, reinforcing retention but posing no dilution risk. Because settlement occurs in cash at separation, shareholders face neither overhang nor voting dilution. From a governance lens, the absence of sales and the modest uptick in accumulated value are benign. Impact on investor sentiment should be minimal.
Campbell Soup Company (CPB) Modulo 4 鈥� attivit脿 degli insider. Il 26 giugno 2025, la Direttrice Sarah Hofstetter ha acquisito 1.348,51 unit脿 di phantom stock, un premio il cui valore corrisponde a una azione ordinaria. Le unit脿 sono state assegnate a un prezzo nominale di 0$ nell'ambito del Piano Pensionistico Supplementare della societ脿 e sono completamente maturate. Dopo la transazione, il totale delle unit脿 di phantom stock detenute da Hofstetter 猫 salito a 25.710,86 unit脿, comprensive di 262,25 unit脿 accumulate tramite il reinvestimento dei dividendi dalla sua ultima segnalazione. Il phantom stock verr脿 liquidato in contanti al momento del pensionamento, dimissioni o licenziamento della direttrice. Non sono state segnalate vendite o cessioni, n茅 variazioni nella propriet脿 di azioni ordinarie non derivate.
Poich茅 il premio rappresenta una normale remunerazione per i direttori e il suo valore di mercato stimato 猫 ben al di sotto delle soglie di rilevanza rispetto alla capitalizzazione di mercato di Campbell, la segnalazione 猫 considerata informativa e non influente sul mercato. Tuttavia, l'assenza di vendite e la continua accumulazione di unit脿 equivalenti a azioni indicano un allineamento costante degli interessi della direttrice con il valore per gli azionisti.
Campbell Soup Company (CPB) presentaci贸n Formulario 4 鈥� actividad de insiders. El 26 de junio de 2025, la Directora Sarah Hofstetter 补诲辩耻颈谤颈贸 1,348.51 unidades de phantom stock, un premio cuyo valor refleja una acci贸n com煤n. Las unidades fueron otorgadas a un precio declarado de $0 bajo el Plan Suplementario de Jubilaci贸n de la empresa y est谩n totalmente consolidadas. Tras la transacci贸n, la tenencia total de phantom stock de Hofstetter aument贸 a 25,710.86 unidades, que ahora incluyen 262.25 unidades acumuladas mediante reinversi贸n de dividendos desde su 煤ltimo reporte. El phantom stock se liquidar谩 en efectivo al momento de la jubilaci贸n, renuncia o despido de la directora. No se reportaron ventas ni disposiciones, y no hubo cambios en la propiedad de acciones comunes no derivadas.
Dado que el premio representa una compensaci贸n rutinaria para directores y su valor de mercado estimado est谩 muy por debajo de los umbrales de materialidad en relaci贸n con la capitalizaci贸n de mercado de Campbell, la presentaci贸n se considera informativa y no que mueva el mercado. Sin embargo, la ausencia de ventas y la continua acumulaci贸n de unidades equivalentes a acciones indican una alineaci贸n constante de los intereses de la directora con el valor para los accionistas.
旌犽波 靾橅攧 旎错嵓雼�(CPB) Form 4 鞝滌稖 鈥� 雮措秬鞛� 頇滊彊. 2025雲� 6鞗� 26鞚�, 鞚挫偓 Sarah Hofstetter臧赌 韺厐 鞀ろ啞 1,348.51 雼渼毳� 旆摑頄堨姷雼堧嫟. 韺厐 鞀ろ啞鞚� 氤错喌欤� 頃� 欤检潣 臧赌旃橂ゼ 氚橃榿頃橂姅 氤挫儊鞛呺媹雼�. 頃措嫻 雼渼霌れ潃 須岇偓鞚� 於旉岸� 韲挫鞐瓣笀 瓿勴殟 頃橃棎 氇呾嫓霅� 臧赌瓴� $0搿� 攵�鞐悩鞐堨溂氅�, 鞕勳爠頌� 氩犾姢韺�(甓岆Μ 頇曥爼)霅� 靸來儨鞛呺媹雼�. 鞚措矆 瓯半灅 頉� Hofstetter 鞚挫偓鞚� 韺厐 鞀ろ啞 齑� 氤挫湢霟夓潃 25,710.86 雼渼搿� 歃濌岸捻枅鞙茧┌, 鞚� 欷� 262.25 雼渼電� 歆�雮� 氤搓碃 鞚错泟 氚半嫻旮� 鞛埇鞛愲ゼ 韱淀暣 雸勳爜霅� 瓴冹瀰雼堧嫟. 韺厐 鞀ろ啞鞚� 鞚挫偓鞚� 鞚�韲�, 靷瀯 霕愲姅 頃搓碃 鞁� 順勱笀鞙茧 鞝曥偘霅╇媹雼�. 韺愲Г雮� 觳橂秳鞚� 氤搓碃霅橃 鞎婌晿鞙茧┌, 牍勴寣靸� 氤错喌欤� 靻岇湢甓� 氤�頇旊弰 鞐嗢棃鞀惦媹雼�.
鞚� 氤挫儊鞚� 鞚挫偓鞐� 雽�頃� 鞚检儊鞝侅澑 氤挫垬鞚措┌, 旌犽波鞚� 鞁滉岸撵礉鞎� 雽�牍� 欷戩殧靹� 旮办鞐� 頉敩 氇� 氙胳箻電� 於旍爼 鞁滌灔 臧赌旃橂ゼ 臧赌歆�瓿� 鞛堨柎, 鞝滌稖 雮挫毄鞚� 鞝曤炒 鞝滉车 氇╈爜鞚挫 鞁滌灔鞐� 鞓來枼鞚� 氙胳範 毵岉暅 靷晥鞙茧 臧勳＜霅橃 鞎婌姷雼堧嫟. 攴鸽熂鞐愲弰 攵堦惮頃橁碃 韺愲Г臧赌 鞐嗞碃 欤检嫕 霌标岸� 雼渼鞚� 歆�靻嶌爜 雸勳爜鞚� 鞚挫偓鞚� 鞚错暣甏�瓿勱岸� 欤检＜ 臧赌旃橃檧 瓿勳啀 鞚检箻頃橁碃 鞛堨潓鞚� 雮橅儉雰呺媹雼�.
Campbell Soup Company (CPB) d茅p么t du formulaire 4 鈥� activit茅 des initi茅s. Le 26 juin 2025, la directrice Sarah Hofstetter a acquis 1 348,51 unit茅s de phantom stock, une attribution dont la valeur refl猫te une action ordinaire. Les unit茅s ont 茅t茅 attribu茅es 脿 un prix d茅clar茅 de 0 $ dans le cadre du Plan de Retraite Suppl茅mentaire de la soci茅t茅 et sont enti猫rement acquises. Apr猫s la transaction, la d茅tention totale de phantom stock de Hofstetter est pass茅e 脿 25 710,86 unit茅s, incluant 262,25 unit茅s accumul茅es par r茅investissement des dividendes depuis son dernier rapport. Le phantom stock sera r茅gl茅 en esp猫ces lors de la retraite, de la d茅mission ou du licenciement de la directrice. Aucune vente ou cession n鈥檃 茅t茅 signal茅e, et il n鈥檡 a eu aucun changement dans la d茅tention d鈥檃ctions ordinaires non d茅riv茅es.
脡tant donn茅 que cette attribution repr茅sente une r茅mun茅ration habituelle des administrateurs et que sa valeur marchande estim茅e est bien en dessous des seuils de mat茅rialit茅 par rapport 脿 la capitalisation boursi猫re de Campbell, le d茅p么t est consid茅r茅 comme informatif et non susceptible d鈥檌nfluencer le march茅. N茅anmoins, l鈥檃bsence de ventes et l鈥檃ccumulation continue d鈥檜nit茅s 茅quivalentes 脿 des actions indiquent un alignement constant des int茅r锚ts de la directrice avec la valeur pour les actionnaires.
Campbell Soup Company (CPB) Form 4 Einreichung 鈥� Insider-Aktivit盲ten. Am 26. Juni 2025 erwarb die Direktorin Sarah Hofstetter 1.348,51 Einheiten von Phantomaktien, einer Zuwendung, deren Wert einer Stammaktie entspricht. Die Einheiten wurden zu einem festgelegten Preis von 0 $ im Rahmen des erg盲nzenden Altersvorsorgeplans des Unternehmens gew盲hrt und sind vollst盲ndig unverfallbar. Nach der Transaktion stieg Hofstetters Gesamtbestand an Phantomaktien auf 25.710,86 Einheiten, einschlie脽lich 262,25 Einheiten, die seit ihrem letzten Bericht durch Dividenden-Reinvestition angesammelt wurden. Phantomaktien werden bei Renteneintritt, R眉cktritt oder K眉ndigung der Direktorin in bar abgewickelt. Es wurden keine Verk盲ufe oder Ver盲u脽erungen gemeldet, und es gab keine 脛nderungen im Besitz von nicht-derivierten Stammaktien.
Da die Zuwendung eine routinem盲脽ige Direktorenverg眉tung darstellt und der gesch盲tzte Marktwert im Vergleich zur Marktkapitalisierung von Campbell weit unter den Wesentlichkeitsschwellen liegt, wird die Einreichung als informativ und nicht als marktbewegend eingestuft. Dennoch signalisieren das Ausbleiben von Verk盲ufen und die fortlaufende Ansammlung von aktien盲quivalenten Einheiten eine anhaltende 脺bereinstimmung der Interessen der Direktorin mit dem Wert f眉r die Aktion盲re.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (date of earliest event reported)
(Exact name of Registrant as specified in its charter)
| (State
or other jurisdiction of incorporation or organization) |
(Commission File Number) |
(I.R.S.
Employer Identification Number) |
(Address of principal executive offices) (Zip code)
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
| The Capital Market | ||||
| The
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.07 Submission of Matters to a Vote of Security Holders.
(a) The 2025 Annual Meeting of Cyclacel Pharmaceuticals, Inc. was held on June 30, 2025.
(b) The results of the matters submitted to a shareholder vote at the Annual Meeting were as follows:
1. Election of Directors: Our shareholders re-elected the following five (5) directors to each serve a three-year term expiring on the date of our 2028 annual meeting of shareholders or until his successor has been duly chosen and qualified.
| 1.A. | Datuk Dr. Doris Wong |
| FOR | AGAINST | ABSTAIN | BROKER NON-VOTE | |||||||||||||||||||||||||||
| Number | % | Number | % | Number | % | Number | % | |||||||||||||||||||||||
| 305,050,384 | 99.97 | % | 0 | 0 | % | 95,025 | 0.03 | % | N/A | N/A | ||||||||||||||||||||
| 1B. | Kiu Cu Seng |
| FOR | AGAINST | ABSTAIN | BROKER NON-VOTE | |||||||||||||||||||||||||||
| Number | % | Number | % | Number | % | Number | % | |||||||||||||||||||||||
| 305,047,294 | 99.97 | % | 0 | 0 | % | 98,115 | 0.03 | % | N/A | N/A | ||||||||||||||||||||
| 1.C. | Kwang Fock Chong |
| FOR | AGAINST | ABSTAIN | BROKER NON-VOTE | |||||||||||||||||||||||||||
| Number | % | Number | % | Number | % | Number | % | |||||||||||||||||||||||
| 305,045,327 | 99.97 | % | 0 | 0 | % | 100,082 | 0.03 | % | N/A | N/A | ||||||||||||||||||||
| 1.D. | Dr. Satis Waran Nair Krishnan |
| FOR | AGAINST | ABSTAIN | BROKER NON-VOTE | |||||||||||||||||||||||||||
| Number | % | Number | % | Number | % | Number | % | |||||||||||||||||||||||
| 305,045,506 | 99.97 | % | 0 | 0 | % | 99,903 | 0.03 | % | N/A | N/A | ||||||||||||||||||||
| 1.E. | Inigo Angel Laurduraj |
| FOR | AGAINST | ABSTAIN | BROKER NON-VOTE | |||||||||||||||||||||||||||
| Number | % | Number | % | Number | % | Number | % | |||||||||||||||||||||||
| 305,045,342 | 99.97 | % | 0 | 0 | % | 100,067 | 0.03 | % | N/A | N/A | ||||||||||||||||||||
2. Approve a Proposed Amendment to the 2018 Equity Incentive Plan. Our shareholders approved a proposed amendment to the Company’s 2018 Equity Incentive Plan to increase the number of shares of Common Stock available for the grant of awards by 4,281,987.
| FOR | AGAINST | ABSTAIN | BROKER NON-VOTE | |||||||||||||||||||||||||||
| Number | % | Number | % | Number | % | Number | % | |||||||||||||||||||||||
| 304,957,049 | 99.94 | % | 168,539 | 0.05 | % | 19,821 | 0.01 | % | N/A | N/A | ||||||||||||||||||||
3. Approve by an Advisory Vote the Executive Compensation. Our shareholders approved by an advisory vote the compensation of our named executive officers and directors, as disclosed in this proxy statement.
| FOR | AGAINST | ABSTAIN | BROKER NON-VOTE | |||||||||||||||||||||||||||
| Number | % | Number | % | Number | % | Number | % | |||||||||||||||||||||||
| 305,004,614 | 99.95 | % | 124,873 | 0.04 | % | 15,922 | 0.01 | % | N/A | N/A | ||||||||||||||||||||
Item 9.01 Financial Statements and Exhibits.
| Exhibit No. | Description | |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Date: June 30, 2025 | Cyclacel Pharmaceuticals, Inc. | |
| By: | /s/ Datuk Dr. Doris Wong Sing Ee | |
| Name: | Datuk Dr. Doris Wong Sing Ee | |
| Title: | Chief Executive Officer | |
Source:
FAQ
How many Campbell Soup (CPB) phantom shares did Director Sarah Hofstetter acquire?
What type of security was involved in the CPB Form 4 filed on 30 June 2025?
Was the transaction a purchase or a sale by the insider?
What is Sarah Hofstetter鈥檚 total phantom-stock holding after the transaction?
When is the phantom stock payable to the director?
